Navigation Links
Kensey Nash to Participate in the RBC Capital Markets Healthcare Conference
Date:12/7/2007

EXTON, Pa., Dec 7 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to participate in a panel discussion on "Helping the Body Regenerate Bone & Tissue" at the 2007 RBC Capital Markets Healthcare Conference.

Douglas G. Evans, Kensey Nash's COO, will participate in the panel discussion on Thursday, December 13th at 8:00 a.m. ET in The Westin New York at Times Square in New York. The conference is by invitation only, however individuals can listen to the live and archived presentation at http://www.wsw.com/webcast/rbc84/panel20 or by visiting the Company's website (http://www.kenseynash.com).

About Kensey Nash Corporation. Kensey Nash Corporation is a leading medical technology company providing innovative solutions and technologies for a wide range of medical procedures. The Company provides an extensive range of products into multiple medical markets, primarily in the endovascular, sports medicine and spine markets. Many of the products are based on the Company's significant expertise in the design, development, manufacturing and processing of absorbable biomaterials, which has led to partnerships to commercialize technologies. Kensey Nash has also commercialized a series of innovative products through its own direct endovascular sales force. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc.


'/>"/>
SOURCE Kensey Nash Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Kensey Nash to Present at the Sidoti Sixth Annual West Coast Emerging Growth Institutional Investor Forum Conference
2. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
3. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
4. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
5. Angiotech to participate in UBS Global Life Sciences Conference
6. Transcept Pharmaceuticals to Participate in Middle-of-the-Night (MOTN) Insomnia Investor Panel
7. Vicus Therapeutics Chief Executive Officer to Participate in BIOTECH 2007 Expert Panels
8. Genzyme to Participate in FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
9. MacroChem To Participate in PIPEs Conference October 18th and 19th in New York City
10. Lev Pharmaceuticals Invites You to Participate in its Q307 Earnings Results Conference Call and Webcast
11. Angiotech to participate in Bank of America 2007 Credit Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2018)... ... August 16, 2018 , ... The opening of the new Titusville ... Technical Services in 2016. Chemko had a well established local presence, servicing the Space ... on projects such as the ongoing work at the Mobile Launch Platform (MLP) in ...
(Date:8/17/2018)... (PRWEB) , ... August 16, 2018 , ... ... testing, announced their results from the AmbryShare project were published today in JAMA ... in the largest exome study ever conducted. , Every year hereditary breast cancer ...
(Date:8/14/2018)... ... , ... Labconco Corporation manufactures laboratory equipment, specializing in ventilation ... produces other lab equipment, such as glassware washers and freeze dryers. Labconco has ... design and manufacturing. , Through this webinar, which is sponsored by ...
(Date:8/14/2018)... ... August 14, 2018 , ... The ... 11th Congress of the Chinese Association of Orthopaedic Surgeons (CAOS) held in partnership ... & Technology Development , Beijing, and Invibio Biomaterial Solutions partnered to ...
Breaking Biology Technology:
(Date:8/21/2018)... MADISON, Wis. (PRWEB) , ... August 21, 2018 ... ... of high throughput screening (HTS) solutions, Bellbrook Labs is dedicated to offering customers ... regarding biochemical assays, visitors will find a seamless transition between products, with relevant ...
(Date:8/17/2018)... ... August 16, 2018 , ... With increasing safety requirements, and ... research projects, are presenting multiple challenges. To be successful in such a competitive environment, ... different aspects of the multiple tasks needed to develop a new drug or to ...
(Date:8/17/2018)... Fla. (PRWEB) , ... August 16, 2018 , ... ... “Company”), the world’s first private cord blood bank to separate and store stem ... People’s Law Center, and Brian Sheehy, M.D. M.A. C.F.A., Founder and Managing Partner ...
Breaking Biology News(10 mins):